MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20.

Abstract

OBJECTIVES:

Podocyte pyroptosis, characterized by inflammasome activation, plays an important role in inflammation-mediated diabetic nephropathy (DN). Our study aimed to investigate whether miR-21-5p in macrophage-derived extracellular vesicles (EVs) could affect podocyte injury in DN.

METHODS:

EVs were extracted after the treatment of RAW 264.7 (mouse macrophage line) with high glucose (HG). The podocyte pyroptosis was determined using the flow cytometry and the western blot. After the knockdown of miR-21-5p in HG-induced RAW264.7 cells, we injected the extracted EVs into DN model mice.

RESULTS:

The level of miR-21-5p was higher in HG-stimulated macrophage-derived EVs than in normal glucose-cultured macrophage-derived EVs. The co-culture of EVs and podocytes promoted reactive oxygen species (ROS) production and activation of inflammatory in MPC5 cells (mouse podocyte line). However, restraint of miR-21-5p in EVs reduced ROS production and inhibit inflammasome activation in MPC5 cells, thereby reducing podocytes injury. Meanwhile, we found that miR-21-5p inhibited the A20 expression through binding with its 3'-untranslated regions in MPC5 cells. Further studies showed that A20 was also involved in the regulation of miR-21-5p of RAW 264.7-derived EVs on MPC5 injury. At the same time, it was also proved in the DN model mice that miR-21-5p in macrophage-derived EVs could regulate podocyte injury.

CONCLUSION:

MiR-21-5p in macrophage-derived EVs can regulate pyroptosis-mediated podocyte injury by A20 in DN.

• Authors: X Ding, N Jing, A Shen, F Guo, Y Song, M Pan, X Ma, L Zhao, H Zhang, L Wu, G Qin, Y Zhao
• Journal: Journal of endocrinological investigation (J Endocrinol Invest) Vol. 44 Issue 6 Pg. 1175-1184 (Jun 2021) ISSN: 1720-8386 [Electronic] Italy
• PMID: 32930981 (Publication Type: Journal Article)

Chemical References

• Inflammasomes
• MIRN21 microRNA, mouse
• MicroRNAs
• Sweetening Agents
• Tumor Necrosis Factor alpha-Induced Protein 3
• Tnfaip3 protein, mouse
• Glucose

Topics

• Animals
• Cell Line
• Cell-Derived Microparticles (metabolism)
• Diabetic Nephropathies (immunology, metabolism)
• Disease Models, Animal
• Gene Expression Regulation
• Glucose (administration & dosage, metabolism)
• Inflammasomes (metabolism)
• Macrophages (metabolism)
• Mice
• MicroRNAs (analysis, metabolism)
• Podocytes (metabolism)
• Pyroptosis (drug effects)
• Sweetening Agents (administration & dosage, metabolism)
• Tumor Necrosis Factor alpha-Induced Protein 3 (genetics)